Angiotensin‐converting enzyme type 2 (ACE2) may link hypertension and disease susceptibility, disease progression, and possibly clinical sequelae of COVID‐19,18, 19 yet the underlying mechanism needs to be further explored. This evidence concerns the gene ACE2 and COVID-19.